-
1
-
-
1942476106
-
Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects
-
5
-
R Stoltz JC Cyong A Shah S Parisi 2004 Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects J Clin Pharmacol 44 5 520 531
-
(2004)
J Clin Pharmacol
, vol.44
, pp. 520-531
-
-
Stoltz, R.1
Cyong, J.C.2
Shah, A.3
Parisi, S.4
-
2
-
-
34347242123
-
Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: A comparison of efficacy, side-effect profile, and cost
-
3
-
H Abali I Celik 2007 Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost Cancer Invest 25 3 135 139
-
(2007)
Cancer Invest
, vol.25
, pp. 135-139
-
-
Abali, H.1
Celik, I.2
-
3
-
-
38949173080
-
Current issues in non-inferiority trials
-
3
-
TR Fleming 2008 Current issues in non-inferiority trials Stat Med 27 3 317 332
-
(2008)
Stat Med
, vol.27
, pp. 317-332
-
-
Fleming, T.R.1
-
4
-
-
0033998179
-
3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting
-
3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting Cancer Invest 18 163 173
-
(2000)
Cancer Invest
, vol.18
, pp. 163-173
-
-
Hesketh, P.J.1
-
5
-
-
33748749890
-
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
-
MS Aapro SM Grunberg GM Manikhas G Olivares T Suarez SA Tjulandin LF Bertoli F Yunus B Morrica F Lordick A Macciocchi 2006 A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy Ann Oncol 17 1441 1449
-
(2006)
Ann Oncol
, vol.17
, pp. 1441-1449
-
-
Aapro, M.S.1
Grunberg, S.M.2
Manikhas, G.M.3
Olivares, G.4
Suarez, T.5
Tjulandin, S.A.6
Bertoli, L.F.7
Yunus, F.8
Morrica, B.9
Lordick, F.10
MacCiocchi, A.11
-
6
-
-
0344412945
-
Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: Results of a phase III, single-dose trial versus dolasetron
-
99-04 Palonosetron Study Group
-
P Eisenberg J Figueroa-Vadillo R Zamora V Charu J Hajdenberg A Cartmell A Macciocchi S Grunberg 99-04 Palonosetron Study Group 2003 Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron Cancer 98 2473 2482
-
(2003)
Cancer
, vol.98
, pp. 2473-2482
-
-
Eisenberg, P.1
Figueroa-Vadillo, J.2
Zamora, R.3
Charu, V.4
Hajdenberg, J.5
Cartmell, A.6
MacCiocchi, A.7
Grunberg, S.8
-
7
-
-
1342267601
-
Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: A dose-ranging clinical study
-
2
-
P Eisenberg FR MacKintosh P Ritch PA Cornett A Macciocchi 2004 Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study Ann Oncol 15 2 330 337
-
(2004)
Ann Oncol
, vol.15
, pp. 330-337
-
-
Eisenberg, P.1
MacKintosh, F.R.2
Ritch, P.3
Cornett, P.A.4
MacCiocchi, A.5
-
8
-
-
33749640979
-
Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: Palonosetron, dexamethasone, and aprepitant
-
8
-
T Grote J Hajdenberg A Cartmell S Ferguson A Ginkel V Charu 2006 Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant J Support Oncol 4 8 403 408
-
(2006)
J Support Oncol
, vol.4
, pp. 403-408
-
-
Grote, T.1
Hajdenberg, J.2
Cartmell, A.3
Ferguson, S.4
Ginkel, A.5
Charu, V.6
-
9
-
-
20444475381
-
Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting
-
4
-
TH Oo PJ Hesketh 2005 Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting Nat Clin Pract Oncol 2 4 196 201
-
(2005)
Nat Clin Pract Oncol
, vol.2
, pp. 196-201
-
-
Oo, T.H.1
Hesketh, P.J.2
-
10
-
-
0028218986
-
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: A Phase III trial by the National Cancer Institute of Canada Clinical Trials Group
-
L Kaizer D Warr P Hoskins 1994 Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a Phase III trial by the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 12 1050 1057
-
(1994)
J Clin Oncol
, vol.12
, pp. 1050-1057
-
-
Kaizer, L.1
Warr, D.2
Hoskins, P.3
|